A guest post from Thomasina Bailey, MD:
I spent Saturday night, March 9, up late in Baltimore at the
AANP session at USCAP. The talks focused
on sellar lesions. The panel consisted of
Drs. Lopez, Kleinschmidt-DeMasters, and Burger. Dr. Lopez
from UVA gave a really great overview of sellar lesions focusing in on
pituitary adenomas. She discussed the
things that are clinically significant in the work-up of pituitary adenomas
along with the controversies over atypical adenomas and carcinomas
of the pituitary. At the end of her talk,
she listed her own WHO classification of pituitary adenomas giving a comparison
to meningioma WHO grading.
The next
lecture was given by Dr. Kleinschmidt-DeMasters of University of Colorado on
What’s New in Inflammatory Pituitary Lesions, Pituicytomas, Spindle Cell
Oncocytomas, and Craniopharyngiomas.
During this hour numerous cases were reviewed. Of particular interest was the
clinical pathological correlation of pharmacological treatment and the
development of hypophysitis. As she
referenced articles and cases she called out audience members who were their
authors. During the course of the talks there was a lot of audience interaction
when comparing and contrasting use of certain antibodies.
The icing on the cake was Dr. Burger's talk
on oddball lesions of the sellar region. He started off the talk by noting that no one will probably ever see in their practices the entities he was about to share. He called on the audience
including some of his former fellows for their thoughts. The last case was of
special interest because he sited a case report from 1855. He talked about going to Welch Library to
find the journal and then went off on an enjoyable tangent about Dr. Welch being the first pathology chair at Hopkins. Spending a Saturday night
at a science talk was super geeky, but I love neuropathology and the pathology history
lesson was a bonus. It was neat to think
about all the really great neuropathologists sitting in the audience as well
as at the podium. I just wish Dr. Perry had sung a little bit in the beginning!
2 comments:
Good times! Is Dr. Lopez's proposed grading scheme for adenomas available in print?
I did not get the feeling that a change was being proposed for the grading scheme. There was one slide which compared and contrasted who meningioma grading to that of pit. adenomas. . . I took this as more of a learning tool.
It was a great talk.
TB
I was wondering if anyone went to the medulloblastoma talk at the Pediatric Pathology earlier that night or to any of the other neuropathology related sessions at USCAP (Lessons and Lesions from Peter Burger’s Notebook, Neuropathology After Dark: Surviving Intraoperative Frozen Section Consultation , or Approach to Non-Neoplastic Surgical Neuropathology)?
Post a Comment